Showing results (2401-2410 of 2,625) with videos related to
Sort By:
Pageof 263
Biorxiv : the Preprint Server for Biology|June 9, 2023
Optimizing In Situ Proximity Ligation Assays for Mitochondria, ER, or MERC Markers in Skeletal Muscle Tissue and CellsDominique C Stephens, Amber Crabtree, Heather K Beasley, et al.Advanced Biology|May 28, 2023
In the Age of Machine Learning Cryo-EM Research is Still Necessary: A Path toward Precision MedicineDominique C Stephens, Amber Crabtree, Heather K Beasley, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 9, 2002
Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis StudyN J Crabtree, H Kroger, A Martin, et al.Biotechnology for Biofuels|May 16, 2018
High-oleate yeast oil without polyunsaturated fatty acidsVasiliki Tsakraklides, Annapurna Kamineni, Andrew L Consiglio, et al.The Journal of Pharmacology and Experimental Therapeutics|April 13, 2018
In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission TomographyAdrian J Mogg, Thomas Eessalu, Megan Johnson, et al.The Lancet. HIV|February 28, 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialJürgen K Rockstroh, Sheetal Kassim, Roger Paredes, et al.HIV Medicine|December 18, 2020
The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infectionM I Figueroa, A Camiro-Zuñiga, P F Belaunzaran-Zamudio, et al.Salud Publica De Mexico|January 16, 2013
[Active tuberculosis in a cohort of HIV-infected inmates in a prison in Mexico City: clinical and epidemiological characteristics]Christian Hernández-León, Florentino Badial-Hernández, Alfredo Ponce-de-León, et al.Plos Neglected Tropical Diseases|October 1, 2015
Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based SurveillanceMiriam Bobadilla-del Valle, Pedro Torres-González, Miguel Enrique Cervera-Hernández, et al.Journal of the American Board of Family Medicine : JABFM|September 16, 2022
How Does Prior Experience Pay Off in Large-Scale Quality Improvement Initiatives?Deborah J Cohen, Bijal A Balasubramanian, Stephan Lindner, et al.Pageof 263